Shimba Shigeki, Komiyama Kazuo, Moro Itaru, Tezuka Masakatsu
Department of Health Science, College of Pharmacy, Nihon University, Narashinodai, Funabashi, Chiba 274-8555.
J Biochem. 2002 Nov;132(5):795-802. doi: 10.1093/oxfordjournals.jbchem.a003289.
The arylhydrocarbon receptor (AhR) is a ligand-activated transcription factor that mediates a spectrum of toxic and biological effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and related compounds. Although the physiological ligand for the AhR has not yet been identified, several reports have suggested that the AhR may play important roles not only in the regulation of xenobiotic metabolism but also in the maintenance of homeostatic functions [Singh et al. (1996) Arch. Biochem. Biophys. 329, 47-55; Crawford et al. (1997) Mol. Pharmacol. 52, 921-927; Chang et al. (1998) Mol. Cell. Biol. 18, 525-535]. Several lines of evidence suggest that one of the possible physiological roles of the AhR is regulation of cell proliferation. In this study, we first showed that treatment of A549 cells with the AhR agonist stimulates cell proliferation. The effect was antagonized by co-treatment with alpha-naphthoflavone. To obtain direct evidence that the AhR regulates cell proliferation, we isolated the clones that overexpress the AhR. These clones grow faster than control cells, and the rate of growth is proportional to the amount of the AhR. Cell cycle analysis revealed that the acceleration of cell growth by overexpression of the AhR is most probably due to shortening of the late M to S phases. Studies on the expression profiles of cell cycle regulators showed that the AhR or AhR ligand induces the expression of DP2, PCNA, and RFC38. DP2 is the transcription factor that forms the functional dimer with E2F and regulates the expression of several genes involved in DNA synthesis. Interestingly, both PCNA and RFC38 are target genes of E2F and the DP complex. Also, both of these factors are involved in regulating DNA polymerase delta activity. E2F activity was substantially increased in both the AhR-overexpressing cells and the AhR-agonist treated cells, suggesting that AhR-activated E2F/DP2 may induce the expression of PCNA and RFC38 and subsequent DNA synthesis. Down-regulation of the expression of the Arnt by RNAi diminished the effects of the AhR on the cell proliferation of the A549 cells. Consequently, we conclude that the AhR, presumably in collaboration with the Arnt, activates the DNA synthesis and the subsequent cell proliferation in A549 cells.
芳烃受体(AhR)是一种配体激活的转录因子,可介导2,3,7,8-四氯二苯并对二恶英(TCDD)及相关化合物的一系列毒性和生物学效应。尽管尚未确定AhR的生理配体,但有几份报告表明,AhR可能不仅在异源物代谢调节中发挥重要作用,还在维持体内稳态功能方面发挥重要作用[辛格等人(1996年)《生物化学与生物物理学文献》329卷,47 - 55页;克劳福德等人(1997年)《分子药理学》52卷,921 - 927页;张等人(1998年)《分子与细胞生物学》18卷,525 - 535页]。有几条证据表明,AhR可能的生理作用之一是调节细胞增殖。在本研究中,我们首先表明用AhR激动剂处理A549细胞可刺激细胞增殖。该效应可被与α-萘黄酮共同处理所拮抗。为了获得AhR调节细胞增殖的直接证据,我们分离了过表达AhR的克隆。这些克隆比对照细胞生长得更快,且生长速率与AhR的量成正比。细胞周期分析表明,AhR过表达导致的细胞生长加速很可能是由于M期末期到S期的缩短。对细胞周期调节因子表达谱的研究表明,AhR或AhR配体可诱导DP2、增殖细胞核抗原(PCNA)和复制因子C38(RFC38)的表达。DP2是与E2F形成功能性二聚体并调节参与DNA合成的几个基因表达的转录因子。有趣的是,PCNA和RFC38都是E2F和DP复合物的靶基因。此外,这两个因子都参与调节DNA聚合酶δ的活性。在AhR过表达细胞和AhR激动剂处理的细胞中,E2F活性均显著增加,这表明AhR激活的E2F/DP2可能诱导PCNA和RFC38的表达以及随后的DNA合成。通过RNA干扰下调芳烃核转运蛋白(Arnt)的表达可减弱AhR对A549细胞增殖的影响。因此,我们得出结论,AhR可能与Arnt协同作用,激活A549细胞中的DNA合成及随后的细胞增殖。